183 related articles for article (PubMed ID: 38015833)
1. Evaluation of point-of-care multiplex polymerase chain reaction in guiding antibiotic treatment of patients acutely admitted with suspected community-acquired pneumonia in Denmark: A multicentre randomised controlled trial.
Cartuliares MB; Rosenvinge FS; Mogensen CB; Skovsted TA; Andersen SL; Østergaard C; Pedersen AK; Skjøt-Arkil H
PLoS Med; 2023 Nov; 20(11):e1004314. PubMed ID: 38015833
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
3. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial.
Brendish NJ; Malachira AK; Armstrong L; Houghton R; Aitken S; Nyimbili E; Ewings S; Lillie PJ; Clark TW
Lancet Respir Med; 2017 May; 5(5):401-411. PubMed ID: 28392237
[TBL] [Abstract][Full Text] [Related]
4. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
5. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use.
Andrews D; Chetty Y; Cooper BS; Virk M; Glass SK; Letters A; Kelly PA; Sudhanva M; Jeyaratnam D
BMC Infect Dis; 2017 Oct; 17(1):671. PubMed ID: 29017451
[TBL] [Abstract][Full Text] [Related]
6. Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units.
Voiriot G; Fartoukh M; Durand-Zaleski I; Berard L; Rousseau A; Armand-Lefevre L; Verdet C; Argaud L; Klouche K; Megarbane B; Patrier J; Richard JC; Reignier J; Schwebel C; Souweine B; Tandjaoui-Lambiotte Y; Simon T; Timsit JF;
BMJ Open; 2021 Aug; 11(8):e048187. PubMed ID: 34408046
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Stewardship in Community-Acquired Pneumonia With Syndromic Molecular Testing: A Randomized Clinical Trial.
Markussen DL; Serigstad S; Ritz C; Knoop ST; Ebbesen MH; Faurholt-Jepsen D; Heggelund L; van Werkhoven CH; Clark TW; Bjørneklett RO; Kommedal Ø; Ulvestad E; Grewal HMS
JAMA Netw Open; 2024 Mar; 7(3):e240830. PubMed ID: 38446481
[TBL] [Abstract][Full Text] [Related]
9. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
10. Improved diagnostics of infectious diseases in emergency departments: a protocol of a multifaceted multicentre diagnostic study.
Skjøt-Arkil H; Heltborg A; Lorentzen MH; Cartuliares MB; Hertz MA; Graumann O; Rosenvinge FS; Petersen ERB; Østergaard C; Laursen CB; Skovsted TA; Posth S; Chen M; Mogensen CB
BMJ Open; 2021 Sep; 11(9):e049606. PubMed ID: 34593497
[TBL] [Abstract][Full Text] [Related]
11. Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR).
Serigstad S; Ritz C; Faurholt-Jepsen D; Markussen D; Ebbesen MH; Kommedal Ø; Bjørneklett RO; Heggelund L; Clark TW; van Werkhoven CH; Knoop ST; Ulvestad E; Grewal HMS;
Trials; 2022 Aug; 23(1):622. PubMed ID: 35915452
[TBL] [Abstract][Full Text] [Related]
12. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
13. Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial.
Althaus T; Greer RC; Swe MMM; Cohen J; Tun NN; Heaton J; Nedsuwan S; Intralawan D; Sumpradit N; Dittrich S; Doran Z; Waithira N; Thu HM; Win H; Thaipadungpanit J; Srilohasin P; Mukaka M; Smit PW; Charoenboon EN; Haenssgen MJ; Wangrangsimakul T; Blacksell S; Limmathurotsakul D; Day N; Smithuis F; Lubell Y
Lancet Glob Health; 2019 Jan; 7(1):e119-e131. PubMed ID: 30554748
[TBL] [Abstract][Full Text] [Related]
14. Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial.
Fartoukh M; Nseir S; Mégarbane B; Cohen Y; Lafarge A; Contou D; Thille AW; Galerneau LM; Reizine F; Cour M; Klouche K; Navellou JC; Bitker L; Rousseau A; Tuffet S; Simon T; Voiriot G;
Clin Microbiol Infect; 2023 Jun; 29(6):734-743. PubMed ID: 36681325
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital's Five-Month Experience.
Posteraro B; Cortazzo V; Liotti FM; Menchinelli G; Ippoliti C; De Angelis G; La Sorda M; Capalbo G; Vargas J; Antonelli M; Sanguinetti M; De Pascale G; Spanu T
Microbiol Spectr; 2021 Dec; 9(3):e0069521. PubMed ID: 34756067
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a clinical decision rule to guide antibiotic prescription in children with suspected lower respiratory tract infection in The Netherlands: A stepped-wedge cluster randomised trial.
van de Maat JS; Peeters D; Nieboer D; van Wermeskerken AM; Smit FJ; Noordzij JG; Tramper-Stranders G; Driessen GJA; Obihara CC; Punt J; van der Lei J; Polinder S; Moll HA; Oostenbrink R
PLoS Med; 2020 Jan; 17(1):e1003034. PubMed ID: 32004317
[TBL] [Abstract][Full Text] [Related]
18. Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial.
Darie AM; Khanna N; Jahn K; Osthoff M; Bassetti S; Osthoff M; Schumann DM; Albrich WC; Hirsch H; Brutsche M; Grize L; Tamm M; Stolz D
Lancet Respir Med; 2022 Sep; 10(9):877-887. PubMed ID: 35617987
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.
Smedemark SA; Aabenhus R; Llor C; Fournaise A; Olsen O; Jørgensen KJ
Cochrane Database Syst Rev; 2022 Oct; 10(10):CD010130. PubMed ID: 36250577
[TBL] [Abstract][Full Text] [Related]
20. Effect of point-of-care susceptibility testing in general practice on appropriate prescription of antibiotics for patients with uncomplicated urinary tract infection: a diagnostic randomised controlled trial.
Holm A; Cordoba G; Møller Sørensen T; Rem Jessen L; Frimodt-Møller N; Siersma V; Bjerrum L
BMJ Open; 2017 Oct; 7(10):e018028. PubMed ID: 29042390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
